For others, its about reaching a weight that feels steady and sustainable
Ozempic, Wegovy, and other semaglutide-based prescription medications are being prescribed for weight loss if the patient is clinically obese
Both sides have recently published a Phase 3 clinical result
Some patients mistakenly inject into areas with significant scarring from previous surgeries or areas that are tender, bruised, or inflamed
The predominant side effects include: Gastrointestinal symptoms : nausea, vomiting, diarrhoea, constipation, and abdominal pain (affecting 10-50% of patients depending on the specific product and dose, particularly during dose escalation) Injection site reactions : redness, itching, or discomfort at the subcutaneous injection site Hypoglycaemia : particularly when combined with insulin or sulphonylureas Decreased appetite : an intended therapeutic effect that contributes to weight loss However, some patients do report changes in urinary frequency or patterns